Stock Watch: The Swings And Roundabouts Of KRAS Inhibitor Competition
Amgen And Mirati Match Too Early To Call
The era of follow-on medicinal chemistry has largely been eliminated by more comprehensive patent protection. Nowadays, investors trade on the differences in safety and efficacy for similar molecules.
